Evaxion A/S (EVAX)

NASDAQ: EVAX · Real-Time Price · USD

3.040

+0.190 (6.67%)

At close: Aug 13, 2025, 4:00 PM

3.060

+0.020 (0.66%)

Pre-market: Aug 14, 2025, 5:49 AM EDT

ASLAN Pharmaceuticals Employees

Evaxion had 46 employees as of December 31, 2024. The number of employees decreased by 3 or -6.12% compared to the previous year.

Employees

46

Change (1Y)

-3

Growth (1Y)

-6.12%

Revenue / Employee

$71,587

Profits / Employee

-$290,022

Market Cap

19.20M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	46	-3	-6.12%
Dec 31, 2023	49	-14	-22.22%
Dec 31, 2022	63	2	3.28%
Dec 31, 2021	61	26	74.29%
Dec 31, 2020	35	-1	-2.78%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

EVAX News

2 days ago - Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025 - GlobeNewsWire
19 days ago - Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 - GlobeNewsWire
4 weeks ago - Evaxion finalizes agreement with EIB to convert debt into equity - GlobeNewsWire
6 weeks ago - Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio - GlobeNewsWire
7 weeks ago - Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus - GlobeNewsWire
2 months ago - Evaxion receives grant funding to design new polio vaccine - GlobeNewsWire
2 months ago - Evaxion Biotech A/S (EVAX) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
2 months ago - Evaxion announces business update and first quarter 2025 financial results - GlobeNewsWire